Huang, YT, Yang, AM, More...
ECLINICALMEDICINE[2589-5370], Published 2026, Volume 91,
收錄情况: WOS
WOS核心合集引用: 0 2024影響因子: 10.0
2.Targeting APOC3 with Olezarsen in Moderate Hypertriglyceridemia.
Tomlinson, Brian
New England Journal of Medicine[0028-4793], Published 2026, Volume 394, Issue 1, Pages 99
收錄情况: SCOPUS
2024影響因子: 78.5
3.Targeting KAT8 alleviates vascular senescence by modulating the INHBA/TGF-β pathway
Lin, Zhongxiao, Xion More...
Molecular Therapy[1525-0016], Published 2026,
收錄情况: SCOPUS
2024影響因子: 12.0
4.An up-to-date review of emerging biologic therapies for hypercholesterolemia
Tomlinson, B
EXPERT OPINION ON BIOLOGICAL THERAPY[1471-2598], Published 2025, Volume 25, Issue 1, Pages 69-78
收錄情况: WOS SCOPUS
WOS核心合集引用: 2 2024影響因子: 4.0
5.Exploring emerging pharmacotherapies for type 2 diabetes patients with hypertriglyceridemia
Tomlinson, B, Chan, More...
EXPERT OPINION ON PHARMACOTHERAPY[1465-6566], Published 2025, Volume 26, Issue 3, Pages 279-289
收錄情况: WOS SCOPUS
WOS核心合集引用: 1 2024影響因子: 2.7
Wang, YF, Wang, XY, More...
ADVANCED SCIENCE[2198-3844], Published 2025, Volume 12, Issue 12,
收錄情况: WOS SCOPUS
WOS核心合集引用: 7 2024影響因子: 14.1
Elshorbagy, A, Valle More...
EUROPEAN HEART JOURNAL[0195-668X], Published 2025, Volume 46, Issue 12, Pages 1127-1140
收錄情况: WOS SCOPUS
WOS核心合集引用: 11 2024影響因子: 35.6
Tomlinson, B, Lao, U More...
ATHEROSCLEROSIS[0021-9150], Published 2025, Volume 407,
收錄情况: WOS
WOS核心合集引用: 0 2024影響因子: 5.7
Zeng, WW, Luo, YN, O More...
FRONTIERS IN PHARMACOLOGY[1663-9812], Published 2025, Volume 16,
收錄情况: WOS SCOPUS
WOS核心合集引用: 1 2024影響因子: 4.8
10.Statin-Related Transaminitis-Is It Necessary to Stop Statins?
Tomlinson, B, Zeng, More...
CARDIOVASCULAR DRUGS AND THERAPY[0920-3206], Published 2025,
收錄情况: WOS SCOPUS
WOS核心合集引用: 0 2024影響因子: 3.1
11.Antibody-Based Therapeutics for Hypercholesterolemia
Tomlinson, B, Chan, More...
BIOLOGICS-TARGETS & THERAPY[1177-5475], Published 2025, Volume 19, Pages 631-649
收錄情况: WOS SCOPUS
WOS核心合集引用: 0 2024影響因子: 3.4
Zeng, WW, Gan, DL, O More...
FRONTIERS IN REPRODUCTIVE HEALTH[2673-3153], Published 2025, Volume 7,
收錄情况: WOS SCOPUS
WOS核心合集引用: 0 2024影響因子: 2.9
13.Lipoprotein(a) - treatments in development
Tomlinson, B, Law, C More...
EXPERT OPINION ON PHARMACOTHERAPY[1465-6566], Published 2025, Volume 26, Issue 17, Pages 1831-1839
收錄情况: WOS SCOPUS
WOS核心合集引用: 0 2024影響因子: 2.7
14.Advances in Dyslipidaemia Treatments: Focusing on ApoC3 and ANGPTL3 Inhibitors
Tomlinson, Brian, Wu More...
Journal of Lipid and Atherosclerosis[2287-2892], Published 2024, Volume 13, Issue 1, Pages 2-20
收錄情况: SCOPUS
Jin, Q, Lau, ESH, Lu More...
DIABETOLOGIA[0012-186X], Published 2024, Volume 67, Issue 5, Pages 837-849
收錄情况: WOS SCOPUS
WOS核心合集引用: 15 2024影響因子: 10.2 发表年影響因子: 10.2
16.Genetic drivers of heterogeneity in type 2 diabetes pathophysiology
Suzuki, K, Hatzikoto More...
NATURE[0028-0836], Published 2024, Volume 627, Issue 8003, Pages 347-357
收錄情况: WOS SCOPUS
WOS核心合集引用: 265 2024影響因子: 48.5 发表年影響因子: 48.5
Tomlinson, B, Chan, More...
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY[1742-5255], Published 2024, Volume 20, Issue 4, Pages 175-179
收錄情况: WOS SCOPUS
WOS核心合集引用: 2 2024影響因子: 3.4 发表年影響因子: 3.4
Tomlinson, B, Chow, More...
HONG KONG MEDICAL JOURNAL[1024-2708], Published 2024, Volume 30, Issue 2, Pages 184-185
收錄情况: WOS SCOPUS
WOS核心合集引用: 2 2024影響因子: 2.6 发表年影響因子: 2.6
Zeng, WW, Chu, TTW, More...
HELIYON[2405-8440], Published 2024, Volume 10, Issue 14,
收錄情况: WOS SCOPUS
WOS核心合集引用: 2 2024影響因子: 3.6 发表年影響因子: 3.6
本系統需要使用 Internet Explorer 9.0 以上Firefox || Chrome瀏覽器
Copyright © 2018 澳門科技大學學者庫